Phio Pharmaceuticals Corp (PHIO)

NASDAQ
Currency in USD
1.390
+0.030(+2.21%)
Closed
After Hours
1.389-0.001(-0.072%)
PHIO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.3201.400
52 wk Range
1.2209.990
Key Statistics
Edit
Prev. Close
1.36
Open
1.37
Day's Range
1.32-1.4
52 wk Range
1.22-9.99
Volume
51.94K
Average Vol. (3m)
6.71M
1-Year Change
-84.08%
Book Value / Share
5.75
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PHIO Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
4.000
Upside
+187.77%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Phio Pharmaceuticals Corp Company Profile

Phio Pharmaceuticals Corp. engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells’ ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors. It is also developing PH-894, an INTASYL compound in IND enabling studies to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, effecting the immune system and the tumor. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is based in Marlborough, Massachusetts.

Compare PHIO to Peers and Sector

Metrics to compare
PHIO
Peers
Sector
Relationship
P/E Ratio
−0.9x−2.0x−0.6x
PEG Ratio
−0.01−0.010.00
Price / Book
1.3x1.2x2.6x
Price / LTM Sales
-64.4x3.0x
Upside (Analyst Target)
194.1%222.1%51.6%
Fair Value Upside
Unlock17.6%9.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.000
(+187.77% Upside)

Earnings

Latest Release
May 11, 2023
EPS / Forecast
-3.15 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

6.9000
SPCB
-3.50%
10.800
QBTS
-3.40%
19.830
SMMT
-1.49%
2.970
BBAI
-14.90%
10.260
RGTI
-8.06%

FAQ

What Is the Phio Pharma (PHIO) Stock Price Today?

The Phio Pharma stock price today is 1.39

What Stock Exchange Does Phio Pharma Trade On?

Phio Pharma is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Phio Pharma?

The stock symbol for Phio Pharma is "PHIO."

What Is the Phio Pharma Market Cap?

As of today, Phio Pharma market cap is 6.59M.

What is Phio Pharma Earnings Per Share?

The Phio Pharma EPS is -12.64.

From a Technical Analysis Perspective, Is PHIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.